Edition:
India

Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

40.42USD
14 Jun 2019
Change (% chg)

$-0.24 (-0.59%)
Prev Close
$40.66
Open
$40.76
Day's High
$40.94
Day's Low
$40.33
Volume
1,376,739
Avg. Vol
1,966,511
52-wk High
$41.99
52-wk Low
$31.57

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)

Overall

Beta: 1.03
Market Cap(Mil.): $40,477.75
Shares Outstanding(Mil.): 1,372.13
Dividend: --
Yield (%): --

Financials

Boston Scientific sees $25 mln hit to 2019 revenue from mesh withdrawal

April 17 Boston Scientific Corp on Wednesday said it expects a setback of about $25 million to its full-year revenue due to the U.S. Food and Drugs Administration's order to halt sales of its transvaginal surgical mesh products.

17 Apr 2019

Edward Lifesciences pays Boston Scientific $180 million to end patent row

Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

15 Jan 2019

UPDATE 2-Edward Lifesciences pays Boston Scientific $180 mln to end patent row

Jan 15 Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

15 Jan 2019

Edward Lifesciences settles patent disputes with Boston Scientific

Jan 15 Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement related to all outstanding patent disputes between the companies, the medical device makers said in a joint statement on Tuesday.

15 Jan 2019

Earnings vs. Estimates